多发性硬化
免疫系统
免疫学
医学
疾病
微生物群
中枢神经系统
炎症性肠病
神经免疫学
炎症
促炎细胞因子
生物信息学
生物
内科学
作者
Bijan Hashemi,Maryam Abdollahi,Sanaz Abbaspour-Aghdam,A. Hazrati,Kosar Malekpour,Shahla Meshgi,Hossein Samadi Kafil,Farhood Ghazi,Mehdi Yousefi,Leila Roshangar,Majid Ahmadi
标识
DOI:10.1016/j.biopha.2022.114195
摘要
Multiple sclerosis (MS) is known as a chronic inflammatory disease (CID) that affects the central nervous system and leads to nerve demyelination. However, the exact cause of MS is unknown, but immune system regulation and inhibiting the function of inflammatory pathways may have a beneficial effect on controlling and improving the disease. Studies show that probiotics can alter the gut microbiome, thereby improving and affecting the immune system and inflammatory responses in patients with MS. The results show that probiotics have a good effect on the recovery of patients with MS in humans and animals. The present study investigated the effect of probiotics and possible therapeutic mechanisms of probiotics on immune cells and inflammatory cytokines. This review article showed that probiotics could improve immune cells and inflammatory cytokines in patients with MS and can play an effective role in disease management and control.
科研通智能强力驱动
Strongly Powered by AbleSci AI